Independent Financial Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Independent Financial Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Buy	+7,097	New	+$209K	﹤0.01%	1416

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Independent Financial Group's CPRX Position: Q2 2026 in Review

Independent Financial Group opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 7,097 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1416 among its holdings.

370 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Independent Financial Group held 7,097 shares of Catalyst Pharmaceutical worth $223K as of Q2 2026.
Catalyst Pharmaceutical was a new Independent Financial Group position in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Independent Financial Group's portfolio in Q2 2026, its #1416 holding.
370 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.